Specially, the targets of the novel CPI such as AR [58], VDR [59], CTSL and Cathepsin B (CTSB) [60] have been reported to be relevant for the treatment of COVID-19, thus these new predicted CPIs that have not been verified are good candidates for wet experiment exploration. The gene discussed is VDR; the disease is COVID-19.